As for the possibility that TACC3 may impact the WHS phenotype in a manner dependent on the dosages of other WHS genes, the identification of an FGFR3-TACC3 fusion protein in human cancer cells has provided some initial insight (Carneiro et al., 2015). The gene discussed is FGFR3; the disease is cancer.